Myositis clinical trials
The registry lists 242 studies for Myositis across more than 10 countries. 103 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-24.
Status
- Completed
- 80
- Recruiting
- 75
- Status unknown
- 25
- Not yet recruiting
- 22
- Active, not recruiting
- 14
- Terminated
- 10
Phase
- Phase 2
- 53
- Phase 1
- 50
- Phase 3
- 24
- Early Phase 1
- 21
- Phase 4
- 6
Where
- United States
- 84
- China
- 51
- France
- 44
- United Kingdom
- 24
- Germany
- 23
- Spain
- 18
Who runs them
Assistance Publique - Hôpitaux de Paris (11) · Peking University People's Hospital (7) · China Immunotech (Beijing) Biotechnology Co., Ltd. (6) · National Institute of Environmental Health Sciences (NIEHS) (6) · Tongji Hospital (5) · Novartis Pharmaceuticals (5) · Central Hospital, Nancy, France (4) · Karolinska Institutet (4)
Studies
Recruiting first, then most recently updated. Showing 50 of 242 — search for more.
- Investigation of Type I Interferon Excess in Patients With Systemic Autoimmune Diseases and Genetic Type I InterferonopathiesNot yet recruitingNCT07837986Not applicable1 country
- Adult and Juvenile MyositisRecruitingNCT000179141 country
- Safety and Efficacy of Universal CAR-T Cells (UWD-CD19) Combined With Immunosuppressants in the Treatment of Refractory Autoimmune DiseasesNot yet recruitingNCT06821659Phase 1/2
- Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune DiseasesRecruitingNCT06828042Phase 1/21 country
- A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory MyopathyEnrolling by invitationNCT05979441Phase 329 countries
- Environmental Risk Factors for the Anti-synthetase SyndromeRecruitingNCT012764701 country
- RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory MyopathyRecruitingNCT06154252Phase 2/32 countries
- Ublituximab in Autoantibody Positive Immune Mediated Necrotizing MyopathyRecruitingNCT07103746Phase 21 country
- A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory MyopathiesNot yet recruitingNCT07789015Phase 324 countries
- Imaging Assessment of Swallowing and Speech Muscles in Inclusion Body MyositisRecruitingNCT078231011 country
- A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]RecruitingNCT05895786Phase 320 countries
- A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.RecruitingNCT06916806Phase 110 countries
- A Study to Learn About a Medicine Called PF-08154225 in Participants With Autoimmune DiseasesNot yet recruitingNCT07782450Phase 1/2
- A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune DiseaseRecruitingNCT07085104Phase 12 countries
- Study Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic Autoimmune Rheumatic DiseasesNot yet recruitingNCT07544225Phase 11 country
- FT839 in Autoimmune DiseasesRecruitingNCT07800871Phase 1/21 country
- A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune DiseaseRecruitingNCT06925542Phase 13 countries
- Mass Spectrometry-based Immune Profiling in Autoimmune DiseasesEnrolling by invitationNCT071882851 country
- A Study to Test CRT-402 in Refractory Autoimmune DiseaseNot yet recruitingNCT07778446Phase 1/21 country
- Treatment Response in Immune-mediated Myositis Associated Rapidly-progressing Interstitial Lung DiseaseRecruitingNCT077752351 country
- Descartes-08 in Autoantibody MyositisRecruitingNCT07391605Phase 21 country
- Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular ResearchNot yet recruitingNCT07737470
- A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)RecruitingNCT06733935Phase 1/23 countries
- A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune DiseasesRecruitingNCT07284797Phase 11 country
- AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.RecruitingNCT06991114Phase 211 countries
- Biomarkers in Autoimmune Disease of Nervous SystemRecruitingNCT065020151 country
- A Study of AZD0120 in Autoimmune DiseasesRecruitingNCT07295847Phase 16 countries
- BCMA-CD19 cCAR-T for the Treatment of Refractory Inflammatory MyopathyRecruitingNCT07715136Phase 11 country
- Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic DiseasesRecruitingNCT07087912Phase 41 country
- CD19/BCMA-Targeted Universal CAR-T Cell Injection for the Treatment of Autoimmune DiseasesNot yet recruitingNCT07596680Early Phase 11 country
- A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune DiseasesRecruitingNCT07115745Phase 110 countries
- Anti-inflammation Treatment for Idiopathic Inflammatory MyopathiesNot yet recruitingNCT07668505Phase 41 country
- MTS109 in Patients With Refractory Autoimmune DiseasesRecruitingNCT07526350Early Phase 11 country
- Adult Autoimmune Myopathies (MAIA)RecruitingNCT04792931Not applicable1 country
- A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)RecruitingNCT07371468Phase 19 countries
- A Study of KITE-363 in Participants With Refractory Autoimmune DiseasesEnrolling by invitationNCT07038447Phase 13 countries
- OM336 in Seropositive Autoimmune DiseasesRecruitingNCT07229144Phase 11 country
- EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular DiseasesRecruitingNCT070773041 country
- A Phase 1 Study of FT819 in B-cell Mediated Autoimmune DiseaseRecruitingNCT06308978Phase 14 countries
- Drug Rediscovery for Rare Immune Mediated Inflammatory DiseasesRecruitingNCT06285539Phase 21 country
- Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.RecruitingNCT07526493Phase 11 country
- Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune DiseasesRecruitingNCT07085676Phase 11 country
- Muscle Imaging Project Using ANatomopathology and Full Field Optical Coherence TomographyNot yet recruitingNCT075522201 country
- Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM)RecruitingNCT07160205Phase 2/31 country
- Muscle Health Measurements Using Electrical Impedance MyographyRecruitingNCT075029891 country
- A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune DiseaseEnrolling by invitationNCT06375993Phase 11 country
- Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune DiseasesRecruitingNCT052514151 country
- Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune DiseasesRecruitingNCT06548607Early Phase 11 country
- An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune DiseasesRecruitingNCT07236762Phase 11 country
- Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune DiseasesRecruitingNCT07236801Phase 11 country